Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-12-04

DOI:

10.1200/jco-25-01210

Affiliations:

42

Authors:

30

Go to article

Institutions	Authors	Share
AGO Study Group, Germany	5.333333	0.18
ARCAGY-GINECO, France	3.333333	0.11
Grupo Español de Cáncer de Ovario (GEICO), Spain	2.833333	0.09
Philipps University of Marburg (Uni Marburg), Germany	0.833333	0.03
Nordic Society of Gynaecological Oncology (NSGO), Denmark	0.833333	0.03
Berlin Institute of Health (BIH), Germany	0.833333	0.03
Kliniken Essen-Mitte, Germany	0.666667	0.02
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany	0.500000	0.02
Centre Oscar Lambret, France	0.500000	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.500000	0.02
University Hospital of Munich (KUM), LMU, Germany	0.500000	0.02
Institut du Cancer de Montpellier (ICM), France	0.500000	0.02
National Center for Tumor Diseases Dresden (NCT Dresden), Germany	0.500000	0.02
Arbeitsgemeinschaft für gynäkologische Onkologie (AGO) Austria, Austria	0.500000	0.02
Vilnius University Hospital Santariskiu Klinikos (Santariškių Klinikos), VU, Lithuania	0.500000	0.02
University Hospital Basel (USB), UB, Switzerland	0.500000	0.02
University Hospitals Leuven (UZ Leuven), Belgium	0.500000	0.02
Centre François Baclesse, France	0.500000	0.02
Swiss Group for Clinical Cancer Research (SAKK), Switzerland	0.500000	0.02
Groupe Hospitalier Diaconesses Croix Saint-Simon, France	0.500000	0.02
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	0.500000	0.02
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany	0.500000	0.02
Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Belgium	0.500000	0.02
University Medical Center Mainz, JGU, Germany	0.500000	0.02
Hospital La Paz Institute for Health Research (IdiPAZ), Spain	0.500000	0.02
Institute Gustave-Roussy (IGR), France	0.500000	0.02
Centre Antoine-Lacassagne (CAL), France	0.500000	0.02
Instituto Valenciano de Oncologia (IVO), Spain	0.500000	0.02
Medical University of Innsbruck (MUI), Austria	0.500000	0.02
University Hospital Duesseldorf (UKD), Germany	0.500000	0.02
Catalan Ornithological Institute (ICO), Spain	0.500000	0.02
Centre Léon Bérard (CLB), France	0.333333	0.01
Claude Bernard University Lyon 1 (UCBL), France	0.333333	0.01
SLK-Kliniken Heilbronn GmbH, Germany	0.333333	0.01
Biomedical Research Institute (INCLIVA), Spain	0.333333	0.01
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain	0.333333	0.01
Oslo University Hospital (OUS), Norway	0.333333	0.01
University of Oslo (UiO), Norway	0.333333	0.01
Ulm University Medical Center, Germany	0.333333	0.01
University Hospital Zurich (UHZ), Switzerland	0.333333	0.01
University Hospital Frankfurt, GU, Germany	0.333333	0.01

Interested in Oncology and Carcinogenesis?